Pharming Group NV (OTCMKTS:PHGUF – Get Free Report)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $1.37, but opened at $1.20. Pharming Group shares last traded at $1.20, with a volume of 10,000 shares.
Pharming Group Trading Down 12.4%
The stock has a 50 day moving average of $1.48 and a 200 day moving average of $1.22. The company has a quick ratio of 2.07, a current ratio of 2.79 and a debt-to-equity ratio of 0.50.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Read More
- Five stocks we like better than Pharming Group
- EV Stocks and How to Profit from Them
- Stardust’s Strategic Lithium Deal Could Be a Game-Changer
- High Flyers: 3 Natural Gas Stocks for March 2022
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
